Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum
Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum have?
Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum has 158 citations in the OpenAlex counts ScholarIQ stores.
When was Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum published?
Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum has 2018 year in the ScholarIQ index.
What is the open-access status of Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum?
Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum has hybrid oa status in the ScholarIQ index.
What is the DOI of Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum?
The DOI for Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum is on the source record.
What is the PMID of Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum?
The PMID for Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum is on the source record.
What is the OpenAlex record for Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum?
The OpenAlex for Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum is on the source record.